|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation | ||||
| Amortization of intangible assets and software | ||||
| Amortization of deferred contract costs | ||||
| Stock-based compensation expense | ||||
| Deferred tax benefit | ||||
| Bad debt expense | ||||
| (Gain) loss on sale of investments | ||||
| (Gain) on installment sale | ||||
| Loss on foreign currency exchange | ||||
| (Gain) loss on lease exit | ||||
| Naming rights accretion expense | ||||
| Change in fair value of deferred consideration | ||||
| Loss on extinguishment of debt | ||||
| Other | ||||
| Other | ||||
| Changes in assets and liabilities, net of effects from acquisitions: | ||||
| Accounts receivable | ||||
| Prepaid expenses and other assets | ||||
| Other long-term assets | ||||
| Accounts payable | ||||
| Accrued liabilities and other | ||||
| Deferred revenue | ||||
| Other long-term liabilities | ||||
| Deferred contract costs | ||||
| Net cash provided by operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchases of client funds available-for-sale securities | ||||
| Proceeds from sale and maturities of client funds available-for-sale securities | ||||
| Purchase of property and equipment | ||||
| Proceeds from note receivable on installment sale | ||||
| Acquisition of intangible assets | ||||
| Acquisition of businesses, net of cash acquired | ||||
| Internally developed software costs | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Capital contribution in Apax Transaction | ||||
| Net change in cash and cash equivalents held to satisfy client funds obligations | ||||
| Payment of contingent consideration | ||||
| Payment of deferred consideration | ||||
| Repayment of promissory note with related party | ||||
| Payment of capital expenditure financing | ||||
| Proceeds from line-of-credit | ||||
| Proceeds from debt | ||||
| Repayments of debt and finance lease obligations | ||||
| Purchase of treasury stock at cost | ||||
| Proceeds from the issuance of common stock sold in the IPO, net of offering costs and underwriting discount | ||||
| Redemption of Redeemable Series A Preferred Stock (acquisition of noncontrolling interest) | ||||
| Withholding taxes paid related to net share settlements | ||||
| Proceeds from exercise of stock options | ||||
| Proceeds from employee stock purchase plan | ||||
| Other financing activities | ||||
| Net cash provided by (used in) financing activities | ||||
| Impact of foreign exchange on cash and cash equivalents | ||||
| Net change in cash, cash equivalents, restricted cash and short-term investments, and funds held for clients | ||||
| Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, beginning of period | ||||
| Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, end of period | ||||
| Supplemental disclosure of non-cash investing, financing and other cash flow information: | ||||
| Capital expenditures in accounts payable | ||||
| Capital expenditures purchased via financing arrangements | ||||
| Cash paid for interest | ||||
| Right-of-use assets obtained in exchange for operating lease liabilities | ||||
| Reconciliation of cash, cash equivalents, restricted cash and short-term investments, and funds held for clients to the Consolidated Balance Sheets | ||||
| Cash and cash equivalents | ||||
| Restricted cash and short-term investments | ||||
| Funds held for clients | ||||
Loading...